Skip to main
VERV
VERV logo

Verve Therapeutics (VERV)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Verve Therapeutics (VERV) Stock

About Verve Therapeutics (VERV)

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Market cap$999.3M
Today's volume674.76K
Revenue (TTM)$59.61M
Avg. daily volume5.5M
EBITDA (TTM)-$201.61M
Open$11.23
Price / earnings ratio-5.32x
Today's range$11.22 - $11.29
Debt / equity14.5x
52 week range$2.86 - $11.41
5 year debt / equity-32.05x
Beta (LTM)1.63x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio9.84x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Verve Therapeutics Stock Rating

What analysts recommend for VERV stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 15%
Buy 15%
Hold 62%
Sell 0%
Strong Sell 8%

Frequently Asked Questions (FAQ)

As of Jul 02, 2025, the market cap for VERV stock is $999.3M

The current P/E ratio for VERV stock is -5.32

The 52-week high for VERV stock is $11.41. The current VERV stock price $undefined is 100.00% below its 52-week high

The 52-week low for VERV stock is $2.86. The current VERV stock price $undefined has increased 100.00% from its 52-week low

No, the VERV stock does not pay dividends to its shareholders

The target price for VERV stock is $26.92 based on the average of what a group of analyst think VERV stock could be worth at a future date. This is not a prediction by Public.com

How to buy VERV stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VERV stock

    Navigate to the Explore page. Then, type VERV into the search bar. When you see VERV stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VERV stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Verve Therapeutics Stock Earnings

The value each VERV share was expected to gain vs. the value that each VERV share actually gained.

Verve Therapeutics (VERV) reported Q1 2025 earnings per share (EPS) of -$0.35, beating estimates of -$0.65 by 46.15%. In the same quarter last year, Verve Therapeutics's earnings per share (EPS) was -$0.59. Verve Therapeutics is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$0.68.

Buy Verve Therapeutics (VERV) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.